Company profile · Biotech & medical
國光生物科技股份有限公司 · 4142
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
Adimmune manufactures and trades serums, vaccines, diagnostic reagents, biological products, bacterial solutions, and raw materials.[1]
The company is based in Taichung, Taiwan.[1]
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$634m | +6.7% | +104.8% |
2024-11 to 2026-10, monthly revenue.
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | −NT$27m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
| Full English name | ADIMMUNE CORPORATION |
|---|---|
| Chinese name | 國光生物科技股份有限公司 |
| Stock code | 4142 (TWSE) |
| Industry | Biotech & medical |
| Founded | 22 Dec 1965 |
| Listed | 03 May 2012 |
| Paid-in capital | NT$4.3bn |
| Chairman | 詹啟賢 |
| President | 詹啟賢 |
| Headquarters | No.3, Sec. 1, Tanxing Rd., Tanzi Township Taichung County 427, Taiwan |
| Website | http://www.adimmune.com.tw/ |
| Official business description | 血清、疫苗、檢驗試劑、生物製劑及其菌液、原料等之加工製造買賣 · 有關西藥、動物用藥品、化學品及飼料添加物等之加工製造買賣 · 前各項產品之進出口貿易與代理 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Generated 2026-11-11 00:39.